Register for our free email digests:
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The former chief financial officer of device manufacturer ArthroCare Corp. pleaded guilty to fraud in a Texas federal court this week. Michael Gluk reportedly took part in a scheme to manipulate stock prices by falsely inflating ArthroCare’s sales.
Latest From Companies
The positive growth trend seen in Israel's digital health industry is galvanizing big players like Medtronic into action to start developing and recognizing synergistic technologies for future business. Medtech Insight met with members of MindUP, Israel's first digital health incubator and the result of a cross-industry partnership, at the MiXiii Biomed conference in Tel Aviv, to discover how the joint venture is driving the next generation of digital innovations.
Early-stage UK businesses took center stage at a medtech-focused investor event held as part of London's Tech Week. The weeklong festival of events, June 12-16, are intended to strengthen London's status as a global tech hub and celebrate cutting-edge innovation.
GE Healthcare CEO John Flannery is taking over from Jeff Immelt as head of GE and replacing Flannery is Kieran Murphy. Current GE CFO Jeff Bornstein has also been promoted to vice-chair.
It was a robust month for medtech M&A deal making with 17 deals in May, making it the busiest month of the year to date. The total number of acquisitions beat the number recorded in May last year and picked up slightly from the 14 deals inked in the previous month.
Oxford Gene Technology announced May 31 that it will become a wholly owned subsidiary of Sysmex, the Japanese in vitro diagnostics company that will gain entry into the cytogenetics market with OGT's fluorescence in situ hybridization and array comparative genomic hybridization products.
How can medical technology improve the lives of our rapidly aging population? Companies from across the Israeli medtech industry, as well as delegates from around the globe, convened at the 16th MIXiii Biomed life sciences and technology meeting in Tel Aviv to discuss the impact of aging and demonstrate the latest innovations in the field.
The mobile-technology company is trying to corner the wireless needs of the health-care industry, and is pushing for adoption of value-based health-care models that would be dependent on more data-sharing to justify costs based on patient outcomes.
Medtronic, medtech's No. 1 player, did not disappoint the market with its final fiscal quarter performance. With revenue and profit figures exceeding analysts' expectations, the group's outlook for fiscal 2018 is also looking equally positive.
vitalityDNA is taking the preventative approach to health care with its personalized health and lifestyle plan offering. The start-up will initially target consumers and then health care companies.
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.